Paul Jarvis
I am a physician-executive with over a decade of global leadership experience in Medical Affairs, evidence strategy, and clinical innovation across cardiovascular and metabolic diseases. I specialise in translating complex science into clinical and commercial impact, having led the global scientific strategy for next-generation biosensors, including continuous lactate monitoring and high-sensitivity troponin.
I work at the intersection of Medical Affairs, Clinical Development, Regulatory, HEOR, Market Access, and Commercial to shape end-to-end asset strategy. My leadership spans clinical utility planning, early and late-phase evidence generation, global IIT/IIS governance, and scientific communication across major markets.
I partner closely with Key Opinion Leaders (KOLs), academic leaders, and global medical societies to build advocacy, align strategic priorities, and influence the future standard of care. My approach is science-led, collaborative, and grounded in improving outcomes for patients with high-risk cardiovascular and metabolic disease.
I thrive in global organisations where scientific clarity, strategic influence, and decisive leadership drive meaningful innovation.
When Your Survival From Sepsis Depends on Where You Are Treated
Sepsis is widely recognised as a time-critical medical emergency. International guidelines emphasise early recognition, prompt antimicrobial therapy, and rapid haemodynamic resuscitation. Despite this apparent consensus, outcomes for patients with sepsis remain strikingly heterogeneous. Survival is not determined solely by disease severity or comorbidity. It is, to a significant extent, determined by the hospital to which…